Nevertheless, inhibiting efferocytosis may not provide substantial benefits for the body because of the effects caused by secondary necrosis, but suppressing efferocytosis and necrosis via inhibition of MerTK and IDO1 may exhibit an anti-tumor effect without damage to the host in breast cancer patients.60 Here, IDO1 is linked to neoplasm.